Burning Rock Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	115	212	73	95	231	10,017
Market Cap Growth	210.09%	191.77%	-23.75%	-58.75%	-97.69%	313.84%
Enterprise Value	66.1	149.73	8.59	10.11	107.06	9,795
Last Close Price	10.89	20.15	6.75	9.30	22.50	95.30
PS Ratio	1.65	2.75	1.03	1.25	2.83	125.36
PB Ratio	1.64	2.77	0.91	0.88	1.38	34.50
P/TBV Ratio	0.22	0.40	0.13	0.12	0.20	0.54
EV/Sales Ratio	0.89	1.94	0.12	0.13	1.31	122.59
Debt / Equity Ratio	0.06	0.05	0.05	0.00	0.01	0.03
Net Debt / Equity Ratio	-0.76	-0.81	-0.80	-0.78	-0.74	-0.76
Net Debt / EBITDA Ratio	6.75	13.16	1.53	1.13	1.00	1.88
Net Debt / FCF Ratio	11.55	12.92	4.79	2.28	1.62	2.05
Asset Turnover	0.64	0.63	0.54	0.41	0.29	0.21
Inventory Turnover	2.55	2.46	2.33	1.75	1.45	1.50
Quick Ratio	2.71	2.67	2.57	2.90	2.57	4.38
Current Ratio	3.05	2.99	2.92	3.36	3.06	4.89
Return on Equity (ROE)	-11.28%	-9.92%	-51.38%	-67.85%	-64.67%	-37.35%
Return on Assets (ROA)	-7.08%	-6.24%	-36.50%	-50.76%	-50.61%	-32.22%
Return on Invested Capital (ROIC)	-51.44%	-49.94%	-251.94%	-284.19%	-264.22%	-245.97%
Return on Capital Employed (ROCE)	-10.34%	-9.20%	-51.24%	-68.55%	-63.61%	-36.83%
Buyback Yield / Dilution	-1.44%	2.26%	-5.05%	0.20%	2.35%	-0.31%
Total Shareholder Return	-1.44%	2.26%	-5.05%	0.20%	2.35%	-0.31%

SEC Filings: 10-K · 10-Q